Seventeen House Republicans broke ranks with GOP leadership on January 8, 2026, voting alongside Democrats to pass a three-year extension of enhanced Affordable Care Act subsidies that had expired just days earlier. The 230-196 vote marked a rare bipartisan rebellion against Speaker Mike Johnson, who had refused to bring the measure to the floor despite warnings that 22 million Americans faced premium increases averaging 114 percent.

The revolt came after Johnson blocked a December vote on the subsidies, which were created during the COVID-19 pandemic and extended by the 2022 Inflation Reduction Act. His decision triggered an immediate crisis: enrollment on the ACA marketplace dropped by 1.4 million people in the first two weeks of January as premiums doubled for those who had relied on the enhanced tax credits.

Among the 17 Republican defectors was Pennsylvania Rep. Brian Fitzpatrick, who led a discharge petition to force the vote. Other notable rebels included representatives from competitive districts where constituents depend heavily on marketplace coverage. Johnson had dismissed calls for an extension, arguing the subsidies were "unsustainable" and that Republicans should wait to address healthcare reform comprehensively.

Premium Shock Hits Millions

The Congressional Budget Office estimated that without the subsidies, 2 million Americans would lose coverage entirely in 2026, while the remaining 22 million enrollees would see their premiums surge from an average of $888 annually to $1,904. The expiration hit hardest in states with less-generous Medicaid expansion and higher baseline premiums.

Health policy analysts at KFF noted that the enhanced subsidies had been instrumental in reducing the uninsured rate to historic lows. Their abrupt end reversed those gains, with initial enrollment data showing sharp declines in 18 states by mid-January.

Senate Faces Pressure

The House passage now puts pressure on the Senate, where Republican leadership has been divided on whether to advance the bill. Some GOP senators have signaled openness to a shorter extension paired with anti-fraud provisions and pharmacy benefit manager reforms, though hardline conservatives oppose any measure that would prop up "Obamacare."

The White House praised the House vote but warned that even a three-year extension is a temporary fix. Democrats are pushing to make the enhanced subsidies permanent as part of broader healthcare legislation, though fiscal conservatives balk at the estimated $25 billion annual cost.

For now, millions of Americans remain in limbo, with insurers warning that continued uncertainty could prompt carriers to exit the marketplace altogether in 2027, further destabilizing coverage options. The Senate is expected to take up the bill in February, though Johnson's opposition suggests a difficult path to reconciliation if Senate Republicans demand changes.